Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cord

Eleanor M. Donnelly, Nicolas N. Madigan, Gemma E. Rooney, Andrew Knight, Bingkun Chen, Bret Ball, Lisa Kinnavane, Yolanda Garcia, Peter Dockery, John Fraher, Padraig M. Strappe, Anthony John Windebank, Timothy O'Brien, Siobhan S. McMahon

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background aims. In this study we investigated the effect of neurotrophin-3 (NT-3) and knockdown of NG2, one of the main inhibitory chondroitin sulfate proteoglycans (CSPG), in the glial scar following spinal cord injury (SCI). Methods. Short hairpin (sh) RNA were designed to target NG2 and were cloned into a lentiviral vector (LV). A LV was also constructed containing NT-3. LV expressing NT-3, shRNA to NG2 or combinations of both vectors were injected directly into contused rat spinal cords 1 week post-injury. Six weeks post-injection of LV, spinal cords were examined by histology for changes in scar size and by immunohistochemistry for changes in expression of CSPG, NT-3, astrocytes, neurons and microglia/macrophages. Motor function was assessed using the Basso, Beattie and Bresnahan (BBB) locomotor scale. Results. Animals that received the combination treatment of LV shNG2 and LV NT-3 showed reduced scar size. These animals also showed an increase in levels of neurons and NG2, a decrease in levels of astrocytes and a significant functional recovery as assessed using the BBB locomotor scale at 2 weeks post-treatment. Conclusions. The improvement in locomotor recovery and decrease in scar size shows the potential of this gene therapy approach as a therapeutic treatment for SCI.

Original languageEnglish (US)
Pages (from-to)1235-1244
Number of pages10
JournalCytotherapy
Volume14
Issue number10
DOIs
StatePublished - Nov 2012

Fingerprint

Neurotrophin 3
Small Interfering RNA
Spinal Cord
Cicatrix
Spinal Cord Injuries
Astrocytes
Neurocan
Chondroitin Sulfate Proteoglycans
Neurons
Contusions
Microglia
Therapeutics
Neuroglia
Genetic Therapy
Histology
Immunohistochemistry
Macrophages
Injections
Wounds and Injuries

Keywords

  • astrocytes
  • axon regeneration
  • chondroitin sulfate proteoglycans
  • glial scar
  • microglia
  • neurotrophin-3
  • NG2
  • spinal cord injury

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Molecular Medicine

Cite this

Donnelly, E. M., Madigan, N. N., Rooney, G. E., Knight, A., Chen, B., Ball, B., ... McMahon, S. S. (2012). Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cord. Cytotherapy, 14(10), 1235-1244. https://doi.org/10.3109/14653249.2012.714865

Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cord. / Donnelly, Eleanor M.; Madigan, Nicolas N.; Rooney, Gemma E.; Knight, Andrew; Chen, Bingkun; Ball, Bret; Kinnavane, Lisa; Garcia, Yolanda; Dockery, Peter; Fraher, John; Strappe, Padraig M.; Windebank, Anthony John; O'Brien, Timothy; McMahon, Siobhan S.

In: Cytotherapy, Vol. 14, No. 10, 11.2012, p. 1235-1244.

Research output: Contribution to journalArticle

Donnelly, EM, Madigan, NN, Rooney, GE, Knight, A, Chen, B, Ball, B, Kinnavane, L, Garcia, Y, Dockery, P, Fraher, J, Strappe, PM, Windebank, AJ, O'Brien, T & McMahon, SS 2012, 'Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cord', Cytotherapy, vol. 14, no. 10, pp. 1235-1244. https://doi.org/10.3109/14653249.2012.714865
Donnelly, Eleanor M. ; Madigan, Nicolas N. ; Rooney, Gemma E. ; Knight, Andrew ; Chen, Bingkun ; Ball, Bret ; Kinnavane, Lisa ; Garcia, Yolanda ; Dockery, Peter ; Fraher, John ; Strappe, Padraig M. ; Windebank, Anthony John ; O'Brien, Timothy ; McMahon, Siobhan S. / Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cord. In: Cytotherapy. 2012 ; Vol. 14, No. 10. pp. 1235-1244.
@article{c5f635306f0b4dbdb1334dca48ad0e9c,
title = "Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cord",
abstract = "Background aims. In this study we investigated the effect of neurotrophin-3 (NT-3) and knockdown of NG2, one of the main inhibitory chondroitin sulfate proteoglycans (CSPG), in the glial scar following spinal cord injury (SCI). Methods. Short hairpin (sh) RNA were designed to target NG2 and were cloned into a lentiviral vector (LV). A LV was also constructed containing NT-3. LV expressing NT-3, shRNA to NG2 or combinations of both vectors were injected directly into contused rat spinal cords 1 week post-injury. Six weeks post-injection of LV, spinal cords were examined by histology for changes in scar size and by immunohistochemistry for changes in expression of CSPG, NT-3, astrocytes, neurons and microglia/macrophages. Motor function was assessed using the Basso, Beattie and Bresnahan (BBB) locomotor scale. Results. Animals that received the combination treatment of LV shNG2 and LV NT-3 showed reduced scar size. These animals also showed an increase in levels of neurons and NG2, a decrease in levels of astrocytes and a significant functional recovery as assessed using the BBB locomotor scale at 2 weeks post-treatment. Conclusions. The improvement in locomotor recovery and decrease in scar size shows the potential of this gene therapy approach as a therapeutic treatment for SCI.",
keywords = "astrocytes, axon regeneration, chondroitin sulfate proteoglycans, glial scar, microglia, neurotrophin-3, NG2, spinal cord injury",
author = "Donnelly, {Eleanor M.} and Madigan, {Nicolas N.} and Rooney, {Gemma E.} and Andrew Knight and Bingkun Chen and Bret Ball and Lisa Kinnavane and Yolanda Garcia and Peter Dockery and John Fraher and Strappe, {Padraig M.} and Windebank, {Anthony John} and Timothy O'Brien and McMahon, {Siobhan S.}",
year = "2012",
month = "11",
doi = "10.3109/14653249.2012.714865",
language = "English (US)",
volume = "14",
pages = "1235--1244",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cord

AU - Donnelly, Eleanor M.

AU - Madigan, Nicolas N.

AU - Rooney, Gemma E.

AU - Knight, Andrew

AU - Chen, Bingkun

AU - Ball, Bret

AU - Kinnavane, Lisa

AU - Garcia, Yolanda

AU - Dockery, Peter

AU - Fraher, John

AU - Strappe, Padraig M.

AU - Windebank, Anthony John

AU - O'Brien, Timothy

AU - McMahon, Siobhan S.

PY - 2012/11

Y1 - 2012/11

N2 - Background aims. In this study we investigated the effect of neurotrophin-3 (NT-3) and knockdown of NG2, one of the main inhibitory chondroitin sulfate proteoglycans (CSPG), in the glial scar following spinal cord injury (SCI). Methods. Short hairpin (sh) RNA were designed to target NG2 and were cloned into a lentiviral vector (LV). A LV was also constructed containing NT-3. LV expressing NT-3, shRNA to NG2 or combinations of both vectors were injected directly into contused rat spinal cords 1 week post-injury. Six weeks post-injection of LV, spinal cords were examined by histology for changes in scar size and by immunohistochemistry for changes in expression of CSPG, NT-3, astrocytes, neurons and microglia/macrophages. Motor function was assessed using the Basso, Beattie and Bresnahan (BBB) locomotor scale. Results. Animals that received the combination treatment of LV shNG2 and LV NT-3 showed reduced scar size. These animals also showed an increase in levels of neurons and NG2, a decrease in levels of astrocytes and a significant functional recovery as assessed using the BBB locomotor scale at 2 weeks post-treatment. Conclusions. The improvement in locomotor recovery and decrease in scar size shows the potential of this gene therapy approach as a therapeutic treatment for SCI.

AB - Background aims. In this study we investigated the effect of neurotrophin-3 (NT-3) and knockdown of NG2, one of the main inhibitory chondroitin sulfate proteoglycans (CSPG), in the glial scar following spinal cord injury (SCI). Methods. Short hairpin (sh) RNA were designed to target NG2 and were cloned into a lentiviral vector (LV). A LV was also constructed containing NT-3. LV expressing NT-3, shRNA to NG2 or combinations of both vectors were injected directly into contused rat spinal cords 1 week post-injury. Six weeks post-injection of LV, spinal cords were examined by histology for changes in scar size and by immunohistochemistry for changes in expression of CSPG, NT-3, astrocytes, neurons and microglia/macrophages. Motor function was assessed using the Basso, Beattie and Bresnahan (BBB) locomotor scale. Results. Animals that received the combination treatment of LV shNG2 and LV NT-3 showed reduced scar size. These animals also showed an increase in levels of neurons and NG2, a decrease in levels of astrocytes and a significant functional recovery as assessed using the BBB locomotor scale at 2 weeks post-treatment. Conclusions. The improvement in locomotor recovery and decrease in scar size shows the potential of this gene therapy approach as a therapeutic treatment for SCI.

KW - astrocytes

KW - axon regeneration

KW - chondroitin sulfate proteoglycans

KW - glial scar

KW - microglia

KW - neurotrophin-3

KW - NG2

KW - spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=84867659030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867659030&partnerID=8YFLogxK

U2 - 10.3109/14653249.2012.714865

DO - 10.3109/14653249.2012.714865

M3 - Article

C2 - 23066785

AN - SCOPUS:84867659030

VL - 14

SP - 1235

EP - 1244

JO - Cytotherapy

JF - Cytotherapy

SN - 1465-3249

IS - 10

ER -